COR vs LEN
Cencora Inc. (COR) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
LEN (LEN) common stock.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
LEN does not have a complete income-statement cache yet.
COR currently screens at market cap $53.91B and trailing P/E 21.2. LEN currently screens at market cap $0.
Not investment advice. Open the COR and LEN stock pages for the full models.
Not investment advice.